Movano Inc. (MOVE) News
Filter MOVE News Items
MOVE News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
MOVE News Highlights
- MOVE's 30 day story count now stands at 2.
- Over the past 11 days, the trend for MOVE's stories per day has been choppy and unclear. It has oscillated between 1 and 1.
Latest MOVE News From Around the Web
Below are the latest news stories about MOVANO INC that investors may wish to consider to help them evaluate MOVE as an investment opportunity.
Evie Ring Welcomes Cardiologist and Stanford University Associate Professor Dr. Fátima Rodriguez to its Medical Advisory BoardAfter recently announcing the establishment of its Medical Advisory Board, Movano Health (Nasdaq: MOVE), a purpose-driven healthcare solutions company at the intersection of medical and consumer devices and makers of the Evie Ring, today shared Dr. Fátima Rodriguez has joined as its newest member. |
Movano Health, Maker of the Evie Ring, Selects Jay Group as its Fulfillment Provider in Preparation for its Commercial LaunchMovano Health (Nasdaq: MOVE) a purpose-driven healthcare solutions company at the intersection of medical and consumer devices and makers of the Evie Ring, today announced the selection of advanced fulfillment provider, Jay Group, as its 3PL. The decision follows months of vetting warehouse providers approved to store, handle and ship the Company's first commercial product currently under FDA review. Through this partnership, the Company will leverage Jay Group's fulfillment analytics and operat |
Movano Health Provides Business Update and Reports Second Quarter 2023 Financial ResultsToday, Movano Health (Nasdaq: MOVE), a purpose-driven healthcare solutions company at the intersection of medical and consumer devices and makers of the Evie Ring, reported financial results for the three months ending June 30, 2023 and provided a business update. |
Evie Ring Establishes Medical Advisory Board Furthering its Commitment to Bringing a Medical-Grade Wearable to WomenToday, Movano Health (Nasdaq: MOVE), a purpose-driven healthcare solutions company at the intersection of medical and consumer devices and makers of the Evie Ring, announced the formation of its Medical Advisory Board. The initial panel is composed of healthcare industry subject matter experts in women's health, mental health, and sleep, who will serve as trusted advisors to the Evie team regarding the development of its medical-grade smart ring for women and provide insights to establish Evie a |
Movano Inc. to Report Second Quarter 2023 Financial Results on Monday, August 14, 2023Movano Inc. (NASDAQ:MOVE) dba Movano Health, a purpose-driven healthcare solutions company at the intersection of medtech and consumer devices and makers of the Evie Ring, today announced that it will report second quarter 2023 financial and operating results on Monday, August 14, 2023. Management will host a conference call and live audio webcast to discuss these results and provide a business update at 2:00 p.m. PDT (5:00 p.m. EDT). |
Movano Health Achieves Major Milestone with First FDA Filing for Evie Ring's Pulse OximeterToday, Movano Health (Nasdaq: MOVE), a purpose-driven healthcare solutions company at the intersection of medical and consumer devices and makers of the Evie Ring, announced that it has submitted a 510(k) premarket notification to the U.S. Food and Drug Administration (FDA) for the Company's first commercial product, the Evie Ring. The submission has passed the first milestone of the review process, an initial review for completeness, and is now under full review by the FDA. |
Stock market's fear gauge prices out U.S. recession risk: JPMorgan analystThe CBOE Volatility Index has priced out the risk of a U.S. recession, according to a JPMorgan currency analyst. Yahoo Finance markets reporter Jared Blikre breaks down what the VIX is showing. |
Movano Health Announces Closing of $9.2 Million Public Offering Including Full Exercise of Over-Allotment OptionMovano Health (Nasdaq: MOVE) ("Movano Health" or the "Company"), a purpose-driven healthcare solutions company at the intersection of medical and consumer devices and makers of the Evie Ring, today announced the closing of its $9.2 million underwritten public offering of 9,200,000 shares of its common stock, including 1,200,000 shares of its common stock issued pursuant to the full exercise by the underwriter of its over-allotment option. The public offering price, before the underwriters' disco |
Movano Health Prices $8.0 Million Public OfferingMovano Health (Nasdaq: MOVE) ("Movano Health" or the "Company"), a purpose-driven healthcare solutions company at the intersection of medical and consumer devices and makers of the Evie Ring, today announced that it has priced an $8.0 million underwritten public offering of 8,000,000 shares of its common stock. The public offering price, before the underwriters' discount and commissions, for each share of common stock is $1.00. All of the securities in the underwritten public offering were sold |
Movano Health Announces Proposed Public OfferingMovano Health (Nasdaq: MOVE) ("Movano Health" or the "Company"), a purpose-driven healthcare solutions company at the intersection of medical and consumer devices and makers of the Evie Ring, today announced that it is proposing to sell shares of its common stock in an underwritten public offering. All of the shares of common stock in the underwritten public offering are to be sold by the Company. The Company intends to grant the underwriter a 30-day option to purchase up to an additional 15% of |